NCT04523116View on ClinicalTrials.gov

Validation of Tie2 as the First Tumour Vascular Response Biomarker for VEGF Inhibitors: VALTIVE1

UnknownOBSERVATIONAL
Enrollment

176

Participants

Timeline

Start Date

January 14, 2021

Primary Completion Date

May 31, 2023

Study Completion Date

June 30, 2023

Conditions
Ovary Cancer
Trial Locations (4)

Unknown

RECRUITING

Royal United Hospitals Bath NHS Foundation Trust, Bath

RECRUITING

The Christie NHS Foundation Trust, Manchester

RECRUITING

East and North Hertfordshire NHS Trust, Northwood

RECRUITING

University Hospital Southampton NHS Foundation Trust, Southampton

Sponsors

Collaborators (1)

Cancer Research UK
All Listed Sponsors
collaborator

Cancer Research UK

OTHER

collaborator

Centre for Trials Research, Cardiff University

UNKNOWN

lead

University of Manchester

OTHER